Category Health, Wellness & Biotech

After the peak of 2021, the size of Y Combinator batches have come down, but the accelerator still launches the largest number of companies in a si...

After a few slow weeks, things picked up slightly concerning big funding deals. Most surprisingly is the fact the week was led by an autonomous dri...

AI's deal-making volume seems to be slowing in the second quarter of 2024 compared to other recent quarters when investors’ appetite showed little ...

Venture funding continues to flow to the radiopharmaceutical sector, with a recent large funding rounds and one of the biggest M&A deal closings to...

Another slow week for funding — the third straight after a significant pick-up in large rounds earlier this year. The dog days of summer seem to al...